|
|
Professor,
Medicine,
Anesthesiology
|
Education: |
|
Degrees:
|
|---|
Ph.D., Baylor College of Medicine, 1993
B.S., New York State University, 1988 -
|
|
|
|
Contact Information:
| Laboratory Address: |
Laboratory
CHS BH-569
UNITED STATES
|
|---|
| Work Address: |
Laboratory
CSH
Los Angeles, CA 90095
UNITED STATES
|
|---|
| Work Address: |
Office
CHS BH-569
Campus - 711520
CA
UNITED STATES
|
|---|
|
Work Phone Number:
|
(310)2065197
|
|---|
|
Additional Information:
Dr. Yibin Wang received his Ph.D. in 1993 from Baylor College of Medicine after completion of his thesis work on liver gene regulation in human genetic disease. In 1998, after post-doctoral training at The Scripps Research Institute and University of California, at San Diego, he joined the faculty of Department of Physiology as assistant professor in University of Maryland School of Medicine, Baltimore, and started to work on signaling mechanisms of heart failure. In 2003, he was promoted to Associated Professor with tenure. In August 2003, Dr. Wang became an Associate Professor with tenure in the School of Medicine at UCLA, Los Angeles, California. Currently, he is a faculty member in the Division of Molecular Medicine at Departments of Anesthesiology and Medicine, and also holds joint appointments at Molecular Biology Institute and Jonsson Comprehensive Cancer Center at UCLA. The main focus of Dr. WangÃÂs research is stress induced signaling mechanism in heart failure. Using molecular genetics and physiological tools, Dr. Wang has demonstrated the pathological role of a number of stress-induced kinases in the development of heart failure and illustrate their potential as therapeutic targets. In addition to his extensive publications in many of the top scientific journals, Dr. Wang also received an Established Investigator Award from American Heart Association, Guident Foundation Visiting Professorship from Case Western University, Ruth L. Kirschstein National Research Service Award from National Institute of Health, and Visiting Scholarship Award from Chinese Natual Science Foundation. He also serves NIH review panels and member of the editorial board of Circulation Research, and Journal of Molecular and Cellular Cardiology.
|
|
Li M, Georgakopoulos D, Lu G, Hester L, Kass DA, Hasday J, Wang Y, p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart., Circulation., 2005, 111 (19), 2494-502.
Petrich BG, Eloff BC, Lerner DL, Kovacs A, Saffitz JE, Rosenbaum DS, Wang Y, Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects., The Journal of biological chemistry. , 2004, 279 (15), 15330-8.
Champion HC, Georgakopoulos D, Takimoto E, Isoda T, Wang Y, Kass DA, Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3., Circulation research. , 2004, 94 (5), 657-63.
Petrich BG, Wang Y, Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies., Trends in cardiovascular medicine. , 2004, 14 (2), 50-5.
Zheng M, Dilly K, Dos Santos Cruz J, Li M, Gu Y, Ursitti JA, Chen J, Ross J, Chien KR, Lederer JW, Wang Y, Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart., American journal of physiology. Heart and circulatory physiology. , 2004, 286 (1), H424-33.
Jiang, M. S. Spicher, K. Boulay, G. Wang, Y. Birnbaumer, L. , Most central nervous system D2 dopamine receptors are coupled to their effecters by Go, Proceedings of the National Academy of Sciences of the United States of America, 2001, 98 ( 6), 3577-3582.
|
|
